Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

PRS injections can improve knee function and reduce pain for up to a year.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Topical tacrolimus is effective and safe for treating alopecia areata.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Combining PRP with Procapil is more effective for hair loss treatment than PRP alone.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Significant progress and investment in advanced therapies and regenerative medicine continue.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

PepACS offers a safer, eco-friendly way to perm, dye, and repair hair.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Trilostane helped a dog with an adrenal tumor feel better and stay healthy.